Ensign Peak Advisors, Inc Vanda Pharmaceuticals Inc. Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $134,724 - $174,182	21,800 Added 41.16%	74,760 $507,000
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $156,636 - $249,888	22,800 Added 75.6%	52,960 $391,000
Q4 2021 Feb 11, 2022	SELL	$15.69 - $21.14 $363,066 - $489,179	-23,140 Reduced 43.41%	30,160 $473,000
Q1 2020 May 11, 2020	BUY	$7.5 - $16.8 $48,750 - $109,200	6,500 Added 13.89%	53,300 $552,000
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $579,384 - $817,596	46,800 New	46,800 $768,000

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $271M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.